Anixa Biosciences Inc Annual Costs and Expenses in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Anixa Biosciences Inc quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
  • Anixa Biosciences Inc Costs and Expenses for the quarter ending July 31, 2024 was $3.59M, a 26.3% increase year-over-year.
  • Anixa Biosciences Inc Costs and Expenses for the twelve months ending July 31, 2024 was $13.7M, a 16.5% increase year-over-year.
  • Anixa Biosciences Inc annual Costs and Expenses for 2023 was $11.2M, a 19.1% decline from 2022.
  • Anixa Biosciences Inc annual Costs and Expenses for 2022 was $13.9M, a 1.66% increase from 2021.
  • Anixa Biosciences Inc annual Costs and Expenses for 2021 was $13.6M, a 36.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.2M -$2.65M -19.1% Nov 1, 2022 Oct 31, 2023 10-K 2024-01-16
2022 $13.9M +$227K +1.66% Nov 1, 2021 Oct 31, 2022 10-K 2024-01-16
2021 $13.6M +$3.67M +36.8% Nov 1, 2020 Oct 31, 2021 10-K 2023-01-04
2020 $9.98M -$2.16M -17.8% Nov 1, 2019 Oct 31, 2020 10-K 2022-01-04
2019 $12.1M -$3.26M -21.2% Nov 1, 2018 Oct 31, 2019 10-K 2021-01-07
2018 $15.4M +$8.96M +139% Nov 1, 2017 Oct 31, 2018 10-K 2020-01-09
2017 $6.44M +$1.63M +33.9% Nov 1, 2016 Oct 31, 2017 10-K 2019-01-11
2016 $4.81M -$5.39M -52.9% Nov 1, 2015 Oct 31, 2016 10-K 2018-01-09
2015 $10.2M +$1.49M +17.1% Nov 1, 2014 Oct 31, 2015 10-K/A 2016-12-08
2014 $8.71M +$405K +4.87% Nov 1, 2013 Oct 31, 2014 10-K 2015-12-23
2013 $8.31M +$3.23M +63.7% Nov 1, 2012 Oct 31, 2013 10-K 2015-01-29
2012 $5.07M -$957K -15.9% Nov 1, 2011 Oct 31, 2012 10-K/A 2014-01-17
2011 $6.03M +$52.6K +0.88% Nov 1, 2010 Oct 31, 2011 10-K 2013-01-29
2010 $5.98M Nov 1, 2009 Oct 31, 2010 10-K 2012-01-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.